Esperion Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Esperion Therapeutics by Vanguard Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $24M | 11M | 2.22 |
2024-03-31 | $24M | 8.8M | 2.68 |
2023-12-31 | $15M | 5.1M | 2.99 |
2023-09-30 | $4.6M | 4.7M | 0.98 |
2023-06-30 | $5.9M | 4.3M | 1.39 |
2023-03-31 | $6.9M | 4.3M | 1.59 |
2022-12-31 | $27M | 4.3M | 6.23 |
2022-06-30 | $27M | 4.3M | 6.36 |
2022-03-31 | $21M | 4.5M | 4.64 |
2021-09-30 | $22M | 1.8M | 12.05 |
2021-06-30 | $49M | 2.3M | 21.15 |
2021-03-31 | $65M | 2.3M | 28.04 |
2020-12-31 | $62M | 2.4M | 26.00 |
2020-09-30 | $86M | 2.3M | 37.17 |
2020-06-30 | $121M | 2.4M | 51.30 |
2020-03-31 | $78M | 2.5M | 31.53 |
2019-12-31 | $158M | 2.6M | 59.63 |
2019-09-30 | $98M | 2.7M | 36.59 |
2019-03-31 | $71M | 1.8M | 40.14 |
2018-12-31 | $78M | 1.7M | 46.10 |
2018-09-30 | $73M | 1.6M | 44.37 |
2018-06-30 | $61M | 1.5M | 39.20 |
2018-03-31 | $107M | 1.5M | 72.34 |
2017-12-31 | $61M | 931k | 65.85 |
2017-09-30 | $44M | 880k | 50.00 |
2017-06-30 | $35M | 756k | 46.27 |
2017-03-31 | $26M | 724k | 35.29 |
2016-12-31 | $7.5M | 601k | 12.50 |
2016-09-30 | $7.9M | 568k | 13.85 |
2016-06-30 | $8.0M | 812k | 9.90 |
2015-12-31 | $16M | 726k | 21.82 |
2015-09-30 | $17M | 727k | 23.64 |
2015-06-30 | $58M | 708k | 81.74 |
2015-03-31 | $37M | 396k | 92.62 |
2014-12-31 | $10M | 250k | 40.51 |
2014-09-30 | $3.9M | 160k | 24.50 |
2014-06-30 | $2.5M | 159k | 15.84 |
2014-03-31 | $2.4M | 159k | 15.11 |
2013-12-31 | $1.9M | 136k | 13.85 |
2013-09-30 | $1.4M | 74k | 18.89 |